Sleep, Oxytocin and Reward Processing in Women in the Postpartum Phase
The Role of Sleep, Oxytocin and Reward Processing in Women in the Postpartum Phase
1 other identifier
observational
100
1 country
1
Brief Summary
During and after pregnancy, a woman's body and brain undergo significant changes that help her adapt to caregiving and emotional needs. However, this period also makes women more susceptible to emotional disorders, such as peripartum depression (PPD), which affects about 10-15% of new mothers. PPD can negatively impact both the mother and her baby, disrupting mood, motivation, and mothering abilities. Hormonal changes and poor sleep are some of the risk factors that might worsen these depressive symptoms. Traditionally, sleep studies on PPD have relied on questionnaires and short-term sleep assessments. With the advent of smartwatches and digital devices, we can now monitor sleep in a home environment over longer periods. Oxytocin, a hormone crucial for childbirth, breastfeeding, and bonding with the baby, is thought to play a role in PPD. Studies suggest that higher levels of oxytocin might be linked to lower levels of postpartum depression, though findings are not always consistent. Oxytocin also affects sleep and is connected to brain areas that regulate reward and motivation. This study aims to explore the relationship between sleep, oxytocin, and reward processing in new mothers. The investigators will include women with varying levels of depressive symptoms and use home-based sleep assessments to gather data. Our goal is to better understand how these factors interact in the postpartum period and how they might influence a mother's mental health and caregiving abilities. The investigators expect that oxytocin levels are reduced in women with higher depressive symptoms and that these reductions are associated with sleep impairments, breastfeeding and altered reward processing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 2, 2024
November 1, 2024
2 years
November 22, 2024
November 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
objective sleep
Objective sleep measures assessed with tracking devices (Fitbit Inspire; Withings sleep analyser) e.g., total time spent in bed, wake time, wake frequency, sleep stages duration.
7 consecutive nights
subjective sleep
Subjective sleep assessed by a daily sleep diary.
7 consecutive days
oxytocin levels
Oxytocin levels assessed with saliva kits.
7 consecutive days
breastfeeding
Assessment of breastfeeding behavior (onset, frequency and duration) with breastfeeding diaries.
7 consecutive days
bonding
Bonding of mother and child assessed with questionnaires.
7 consecutive days
reward processing/motivation
Assessment of effort-based motivation using the effort allocation task.
7 consecutive days
Eligibility Criteria
Research participants will be recruited in the area of Uppsala, Sweden.
You may qualify if:
- Age: 18-40
- Biological sex/gender: female
- Swedish/English fluency
- Postpartum phase: 6 weeks to 1 year
You may not qualify if:
- Age \< 18
- Neonatal complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Research Training Group 2804lead
- Uppsala Universitycollaborator
- Uppsala University Hospitalcollaborator
Study Sites (1)
University of Uppsala
Uppsala, Sweden, 751 24, Sweden
Biospecimen
saliva samples for salivary oxytocin analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2024
First Posted
December 2, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 2, 2024
Record last verified: 2024-11